UCI Health Laguna Hills — Laguna Hills, California

Public research footprint of UCI Health Laguna Hills, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Recurrent Diffuse Large B-Cell Lymphoma · Myelodysplastic Syndrome With Excess Blasts · Pancreatic Acinar Cell Carcinoma · Chronic Lymphocytic Leukemia

Recently updated registry entries

NCT05600894 — Venetoclax in Combination With ASTX727 for the Treatment of Chronic Myelomonocytic… (Active Not Recruiting)
NCT04269902 — Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or… (Recruiting)
NCT06943872 — A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UCI Health Laguna Hills?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.